Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Poliomyelitis Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Poliomyelitis Vaccines Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Poliomyelitis Vaccines Market
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
...
Major Type of Poliomyelitis Vaccines Covered in XYZResearch report:
IPV
OPV
Application Segments Covered in XYZResearch Market
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Poliomyelitis Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 IPV -Product Introduction and Major Manufacturers
1.1.2 OPV -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.1.1 China Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.1.2 China Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.2.1 EU Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.2.2 EU Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.3.1 USA Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.3.2 USA Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.4.1 Japan Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.4.2 Japan Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.5.1 India Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.5.2 India Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.6.1 Southeast Asia Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.7.1 South America Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.7.2 South America Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Poliomyelitis Vaccines Status and Prospect (2015-2026)
2.8.1 Poliomyelitis Vaccines Market Size and Growth Rate (2015-2026)
2.8.2 Poliomyelitis Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Poliomyelitis Vaccines Market Assessment by Segment
3.1 Global Poliomyelitis Vaccines Capacity and Growth Rate
3.2 Global Poliomyelitis Vaccines Sales by Type
3.3 Global Poliomyelitis Vaccines Sales Revenue by Type
3.4 Global Poliomyelitis Vaccines Consumption by Application
4 Global Poliomyelitis Vaccines Market Assessment by Regions
4.1 Global Poliomyelitis Vaccines Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Poliomyelitis Vaccines Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Poliomyelitis Vaccines Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Poliomyelitis Vaccines Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Poliomyelitis Vaccines Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Poliomyelitis Vaccines Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Poliomyelitis Vaccines Sales Market Share of Manufacturers (2019-2020)
6.3 Global Poliomyelitis Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
7 Poliomyelitis Vaccines Competitive Analysis
7.1 Sanofi
7.1.1 Sanofi Company Profiles
7.1.2 Sanofi Product Introduction
7.1.3 Sanofi Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 GSK
7.2.1 GSK Company Profiles
7.2.2 GSK Product Introduction
7.2.3 GSK Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bibcol
7.3.1 Bibcol Company Profiles
7.3.2 Bibcol Product Introduction
7.3.3 Bibcol Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Serum Institute
7.4.1 Serum Institute Company Profiles
7.4.2 Serum Institute Product Introduction
7.4.3 Serum Institute Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Tiantan Biological
7.5.1 Tiantan Biological Company Profiles
7.5.2 Tiantan Biological Product Introduction
7.5.3 Tiantan Biological Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 IMBCA
7.6.1 IMBCA Company Profiles
7.6.2 IMBCA Product Introduction
7.6.3 IMBCA Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Company Profiles
7.7.2 Panacea Biotec Ltd Product Introduction
7.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Bio-Med
7.8.1 Bio-Med Company Profiles
7.8.2 Bio-Med Product Introduction
7.8.3 Bio-Med Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Company Profiles
7.9.2 Halfkin Bio-Pharmaceuticals Product Introduction
7.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion